Pacanowski MA - Search Results

1

Acute pain pathways: protocol for a prospective cohort study.

Jeffery MM, Ahadpour M, Allen S, Araojo R, Bellolio F, Chang N, Ciaccio L, Emanuel L, Fillmore J, Gilbert GH, Koussis P, Lee C, Lipkind H, Mallama C, Meyer T, Moncur M, Nuckols T, Pacanowski MA, Page DB, Papadopoulos E, Ritchie JD, Ross JS, Shah ND, Soukup M, St Clair CO, Tamang S, Torbati S, Wallace DW, Zhao Y, Heckmann R. Jeffery MM, et al. Among authors: pacanowski ma. BMJ Open. 2022 Jul 5;12(7):e058782. doi: 10.1136/bmjopen-2021-058782. BMJ Open. 2022. PMID: 35790333 Free PMC article.

2

Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.

Blaus A, Madabushi R, Pacanowski M, Rose M, Schuck RN, Stockbridge N, Temple R, Unger EF. Blaus A, et al. Circulation. 2015 Oct 13;132(15):1425-32. doi: 10.1161/CIRCULATIONAHA.114.009761. Circulation. 2015. PMID: 26459078

3

Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.

Drozda K, Pacanowski MA. Drozda K, et al. Among authors: pacanowski ma. Pharmacotherapy. 2017 Sep;37(9):1000-1004. doi: 10.1002/phar.1971. Epub 2017 Jul 26. Pharmacotherapy. 2017. PMID: 28605049 Review.

4

Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017.

Ramamoorthy A, Knepper TC, Merenda C, Mendoza M, McLeod HL, Bull J, Zhang L, Pacanowski M. Ramamoorthy A, et al. Clin Pharmacol Ther. 2018 Nov;104(5):940-948. doi: 10.1002/cpt.1180. Epub 2018 Sep 14. Clin Pharmacol Ther. 2018. PMID: 30218447 Free PMC article.

5

Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data.

Weaver JL, Wu W, Hyland PL, Lim R, Smpokou P, Pacanowski M. Weaver JL, et al. Clin Pharmacol Ther. 2022 Jul;112(1):58-61. doi: 10.1002/cpt.2414. Epub 2021 Oct 3. Clin Pharmacol Ther. 2022. PMID: 34496049 Free PMC article. Review.

6

Model-Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare Diseases.

Li RJ, Ma L, Li F, Li L, Bi Y, Yuan Y, Li Y, Xu Y, Zhang X, Liu J, Bhattaram VA, Wang J, Schuck R, Pacanowski M, Zhu H. Li RJ, et al. Among authors: ma l, pacanowski m. J Clin Pharmacol. 2022 Dec;62 Suppl 2:S27-S37. doi: 10.1002/jcph.2143. J Clin Pharmacol. 2022. PMID: 36461744 Review.

7

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Schuck RN, Woodcock J, Zineh I, Stein P, Jarow J, Temple R, Permutt T, LaVange L, Beaver JA, Charlab R, Blumenthal GM, Dorff SE, Leptak C, Lemery S, Rogers H, Chowdhury B, Litwack ED, Pacanowski M. Schuck RN, et al. Clin Pharmacol Ther. 2018 Aug;104(2):282-289. doi: 10.1002/cpt.1041. Epub 2018 Feb 23. Clin Pharmacol Ther. 2018. PMID: 29473145 Free PMC article. Review.

8

An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials.

Adeniyi O, Ramamoorthy A, Schuck R, Sun J, Wilson J, Zineh I, Pacanowski M. Adeniyi O, et al. Clin Pharmacol Ther. 2019 Oct;106(4):841-846. doi: 10.1002/cpt.1473. Epub 2019 Jun 20. Clin Pharmacol Ther. 2019. PMID: 31002380

9

Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects.

Liu J, Jadhav PR, Amur S, Fleischer R, Hammerstrom T, Lewis L, Naeger L, O'Rear J, Pacanowski M, Robertson S, Seo S, Soon G, Birnkrant D. Liu J, et al. Hepatology. 2013 Mar;57(3):897-902. doi: 10.1002/hep.25764. Epub 2012 Dec 28. Hepatology. 2013. PMID: 22487907

10

Precision Medicine 2030.

Pacanowski M, Liu Q. Pacanowski M, et al. Clin Pharmacol Ther. 2020 Jan;107(1):62-64. doi: 10.1002/cpt.1675. Epub 2019 Nov 28. Clin Pharmacol Ther. 2020. PMID: 31782136 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters